Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. (Q53627473)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. |
scientific article |
Statements
Valsartan improves resting skin blood flow in type 2 diabetic patients and reduces poly(adenosine diphosphate-ribose) polymerase activation. (English)
1 reference
Gautam Shrikhande
1 reference
Lalita Khaodhiar
1 reference
Salvatore Scali
1 reference
Christina Lima
1 reference
Matthew Hubbard
1 reference
Katherine Dudley
1 reference
Om Ganda
1 reference
Christiane Ferran
1 reference
Aristidis Veves
1 reference
1 April 2006
1 reference
43
1 reference
760-70; discussion 770-1
1 reference
4
1 reference
Identifiers
1 reference